Long-term assessment of functional capacity, muscle function, lung function, and quality of life in survivors of ventilator-associated pneumonia

LM Dias, JA da Cruz, AJ Lopes - Heliyon, 2024 - cell.com
Background and objective The many patients who develop ventilator-associated pneumonia
(VAP) have generated numerous VAP survivors who are not followed up in the long term …

[HTML][HTML] Predictors of Treatment Failure and Mortality among Patients with Septic Shock Treated with Meropenem in the Intensive Care Unit

MZ Mazlan, AG Ghazali, M Omar… - … Malaysian Journal of …, 2024 - ncbi.nlm.nih.gov
Background The aim of the study was to determine the predictors of meropenem treatment
failure and mortality in the Intensive Care Unit (ICU). Methods This was a retrospective …

[HTML][HTML] The ongoing challenge of ventilator-associated pneumonia: Epidemiology, prevention, and risk factors for mortality in a secondary care hospital intensive care …

C Semet - Infection Prevention in Practice, 2023 - Elsevier
Background Ventilator-associated pneumonia (VAP) is a leading cause of morbidity and
mortality among intensive care unit infections. Despite various preventive measures, the …

Increased ventilator utilization, ventilator-associated pneumonia, and mortality in non-COVID patients during the pandemic

VO Okpujie, FE Uwumiro, M Bojerenu… - Baylor University …, 2024 - Taylor & Francis
Background This study examined ventilator utilization, ventilator-associated pneumonia
(VAP) incidence, and mortality among non-COVID patients requiring mechanical ventilation …

Multidrug-resistant pathogens and ventilator-associated pneumonia in critically ill COVID-19 and non-COVID-19 patients: a prospective observational monocentric …

G Montrucchio, E Balzani, G Sales, A Vaninetti… - Respiratory …, 2024 - Springer
Background The COVID-19 pandemic has increased the incidence of ventilator-associated
pneumonia (VAP) among critically ill patients. However, a comparison of VAP incidence in …

New insights into pneumonia in patients on prolonged mechanical ventilation: need for a new paradigm addressing dysbiosis

J Rello, J Schrenzel, AM Tejo - Jornal Brasileiro de Pneumologia, 2021 - SciELO Brasil
Ventilator-associated pneumonia (VAP) is related to poor outcomes and is most commonly
treated with the use of antibiotic therapy in ICUs. The Infectious Diseases Society of America …

Participant-and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis

I Martin-Loeches, AF Shorr, MH Kollef… - Open Forum …, 2023 - academic.oup.com
Abstract Background In the RESTORE-IMI 2 trial, imipenem/cilastatin/relebactam (IMI/REL)
was noninferior to piperacillin/tazobactam in treating hospital-acquired bacterial …

Prognostic role of serum adrenomedullin in patients with ventilator associated pneumonia

TA Helmy, HH Tammam, ME Leuis… - Advances in Respiratory …, 2022 - mdpi.com
Highlights Ventilator associated pneumonia (VAP) is a common type of sepsis in
mechanically ventilated patients that can progress to septic shock and increased mortality …

[HTML][HTML] Avaliação do impacto de uma intervenção educacional em Pneumonia Associada à Ventilação Mecânica

IM Kunzler, S Omizzollo, SFMS Shama - Fisioterapia e Pesquisa, 2021 - SciELO Brasil
RESUMO A Pneumonia Associada à Ventilação Mecânica consiste na afecção do
parênquima pulmonar em pacientes ventilados artificialmente. Considerada um problema …

[HTML][HTML] The Effect of Ventilator-Associated Pneumonia on the Time-to-Extubation in Adult and Pediatric Intensive Care Unit Patients Requiring Mechanical Ventilation …

R Turkistani, AS Aghashami, SS Badhduoh, RT Fadhel… - Cureus, 2024 - ncbi.nlm.nih.gov
Introduction: Ventilator-associated pneumonia (VAP) ranks as a prominent hospital-acquired
infection. VAP has been shown to have a detrimental impact on patients and healthcare …